3,8,13-Cyclotetradecatriene-1,7-diol,3,7,13-trimethyl-10-(1-methylethyl)-, (1R,3E,7R,8E,10S,13E)- (185117-70-8)

Identification
Name:	3,8,13-Cyclotetradecatriene-1,7-diol,3,7,13-trimethyl-10-(1-methylethyl)-, (1R,3E,7R,8E,10S,13E)-
Synonyms:	3,8,13-Cyclotetradecatriene-1,7-diol,3,7,13-trimethyl-10-(1-methylethyl)-, [1R-(1R,3E,7R,8E,10S*,13E)]-; Sartol A
CAS:	185117-70-8
Molecular Formula:	C20H34 O2
Molecular Structure:
Properties
Safety Data

Other Product

3,8-Cyclotridecadien-1-one,7-hydroxy-13-(hydroxymethyl)-3,7,13-trimethyl-10-(1-methylethyl)-,(3E,7R,8E,10S,13S)-
3,5,9,13-Cyclotetradecatetraene-1,2-diol,6,10,14-trimethyl-3-(1-methylethyl)-, (1R,2R,3E,5Z,8E,13E)- (9CI)
3,8,12-Cyclotetradecatriene-1,2-diol,2,8,12-trimethyl-5-(1-methylethyl)-, (1R,2S,3E,5S,8E,12Z)-
3,8,12-Cyclotetradecatriene-1,2-diol,2,8,12-trimethyl-5-(1-methylethyl)-, (1R,2S,3E,5S,8E,12E)-
4,8,13-Cyclotetradecatriene-1,3-diol,1,5,9-trimethyl-12-(1-methylethyl)-, (1S,3R,4E,8E,12S,13E)-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-[(3-methoxyphenyl)methyl]-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
17-Oxa-1,4,7,23-tetraazabicyclo[17.3.1]tricos- 13-ene-2,5,8,18-tetrone,16-[(2S,3E,5E,9S,- 10S)-11-[(2S,3R,4S,5S,6R,9S,11S)-9-ethyl-4- hydroxy-3,5,11-trimethyl-8-oxo-1-oxa-7- azaspiro[5.5]undec-2-yl]-2,10-dihydroxy-3,9- dimethyl-3,5-undecadienyl]-10,12-dihydroxy- 3-[(3-hydroxyphenyl)methyl]-11-methyl-6- (1-methylethyl)-9-(3-oxobutyl)-,(3S,6S,9R,- 10R,11S,12S,13E,19S)-
13H-12,16-Imino-2H,5H-pyrano[3,2-o][1,7,10,- 13]oxatriazacyclotetracosine-5,8,11,17(14H)- tetrone,19-[(1E,3E,7S,8S)-9-[(2S,3R,4S,5S,- 6R,9S,11S)-9-ethyl-4-hydroxy-3,5,11- trimethyl-8-oxo-1-oxa-7-azaspiro[5.5]undec- 2-yl]-8-hydroxy-1,7-dimethyl-1,3- nonadienyl]-3,4,4a,6,7,9,10,15,16,19,20,25,26,- 26a-tetradecahydro-25-hydroxy-10-[(3- hydroxyphenyl)methyl]-2-methoxy-2,26- dimethyl-7-(1-methylethyl)-,(2S,4aR,7S,10S,- 16S,19S,21E,23E,25S,26S,26aR)-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-((4-hydroxyphenyl)methyl)-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-10-((3,4,5-trimethoxyphenyl)methyl)-, 1,1-dimethylethyl ester, (7S-(7R*,10S*,12R*,13R*))-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 10-[(3,4-dimethoxyphenyl)methyl]-12-hydroxy-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
2-Oxa-5,8,14-triazapentadecan-15-oic acid, 12-hydroxy-10-[(2-methoxyphenyl)methyl]-7-(1-methylethyl)-6,9-dioxo-13-(phenylmethyl)-, 1,1-dimethylethyl ester, [7S-(7R*,10S*,12R*,13R*)]-
Oxacyclohexadeca-3,5,9,13-tetraen-2-one,8-hydroxy-3,5,7-trimethyl-16-[(1S,3E,6S,7R,8S,9R,10S)-6,8,10-trihydroxy-1,7,9-trimethyl-3-undecen-1-yl]-,(3E,5E,7R,8R,9E,13E,16S)-
3,8,11,13-Cyclotetradecatetraene-1,7-diol,3,7,11-trimethyl-14-(1-methylethyl)-, (1S,3E,7R,8E,11E,13Z)-
2,6,10-Cyclotetradecatriene-1,4-diol,2,6,10-trimethyl-13-(1-methylethenyl)-, (1S,2E,4R,6E,10E,13S)-
13-Oxabicyclo[10.1.0]tridec-8-en-6-one,4,12-dimethyl-7-(1-methylethenyl)-9-(1-methylethyl)-,(1R,4S,7S,8E,12R)-rel-(+)- (9CI)
4,10,13-Cyclotetradecatriene-1,3,6-triol,1,5,11-trimethyl-8-(1-methylethenyl)-, (1R,3R,4E,6S,8S,10E,13E)-
8,17-Dioxabicyclo[14.1.0]heptadeca-4,10,12-trien-9-one,7-[(1S,3E,6S,7R,8R,9S,10S)-6,8-dihydroxy-10-methoxy-1,7,9-trimethyl-3-undecen-1-yl]-2,15-dihydroxy-10,12,14-trimethyl-,(1S,2R,4E,7S,10E,12E,14R,15S,16S)-
2-[(8'R,9'S,10'S,13'S,14'S)-13'-methyl-1',2',4',7',8',9',11',12',13',14',15',16'-dodecahydro-10'H-dispiro[1,3-dioxolane-2,17'-cyclopenta[a]phenanthrene-3',2''-[1,3]dioxolan]-10'-yl]ethanamine acetate (1:1)
1/C13H10O/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1-8,13-14